TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression November 30, 2012
TCL Archive NCI Should Toughen Deadlines, Quality, in RAID program, Advisory Committee Says. October 6, 2006
TCL Archive Bill Planned To Okay Medicare/Medicaid Payment For 100% Of Outpatient Anticancer Drug Costs February 16, 1979
